TFF PHARMACEUTICALS, INC. Retained Earnings
TFF PHARMACEUTICALS, INC. had Retained Earnings of -$132.09 million as of 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-11-20
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$132.09M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$128.55M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$124.07M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$118.33M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-09-30 | -$132.09M 10-Q · filed 2024-11-20 |
| 2024-06-30 | -$128.55M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$124.07M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$118.33M 10-Q · filed 2024-11-20 |
| 2023-09-30 | -$113.57M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$109.16M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$104.14M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$97.09M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$89.72M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$82.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$73.69M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$65.32M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$55.27M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$46.59M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$41.93M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$34.28M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$28.38M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$23.33M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$19.51M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$15.71M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$11.05M 10-Q · filed 2019-12-09 |
| 2018-12-31 | -$3.84M 10-K · filed 2020-03-27 |